SCHEMBL1751915

SCHEMBL1751915

CN(C)C(=O)CC1C(=O)N(Cc2ccccc2)c2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CDC25A P30304 1/20 0.50
CACNA1G O43497 1/20 0.49
CACNA1H O95180 1/20 0.49
CACNA1I Q9P0X4 1/20 0.49
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
POLB P06746 2/20 0.46
ALDH1A1 P00352 3/20 0.46
TSHR P16473 1/20 0.46
EP300 Q09472 2/20 0.43
KDM4E B2RXH2 1/20 0.42
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
GAA P10253 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
STAT6 P42226 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6668109 0.79 FNTA (0.49) CDC25ACACNA1GCACNA1HCACNA1IMEN1
SCHEMBL6669921 0.76 MEN1 (0.42) CDC25ACACNA1GCACNA1HCACNA1IMEN1
SCHEMBL29385257 0.74 MEN1 (0.61) CACNA1GCACNA1HCACNA1IMEN1KMT2A
SCHEMBL6825068 0.73 CACNA1G (0.55) CACNA1GCACNA1HCACNA1IMEN1KMT2A
SCHEMBL30345008 0.73 EP300 (0.48) CDC25ACACNA1GCACNA1HCACNA1IMEN1
SCHEMBL7741006 0.73 TSHR (0.47) CDC25AMEN1KMT2APOLBALDH1A1
SCHEMBL38661561 0.71 PARK7 (0.52) CACNA1GCACNA1HCACNA1IMEN1KMT2A
SCHEMBL7611369 0.71 ALDH1A1 (0.77) CACNA1GCACNA1HCACNA1IMEN1KMT2A
SCHEMBL7611374 0.71 ALDH1A1 (0.77) CACNA1GCACNA1HCACNA1IMEN1KMT2A
SCHEMBL7828191 0.71 POLB (0.45) CACNA1GCACNA1HCACNA1IMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1572647-B1 SYNTHESIS OF AMINES AND INTERMEDIATES FOR THE SYNTHESIS THEREOF BASF SE (DE) 2016-09-21 EP disclosed
EP-1572647-B1 SYNTHESIS OF AMINES AND INTERMEDIATES FOR THE SYNTHESIS THEREOF BASF SE (DE) 2016-09-21 EP disclosed
US-8822702-B2 Synthesis of amines and intermediates for the synthesis thereof BASF SE (DE) 2014-09-02 US disclosed
US-8822702-B2 Synthesis of amines and intermediates for the synthesis thereof BASF SE (DE) 2014-09-02 US disclosed
US-8822702-B2 Synthesis of amines and intermediates for the synthesis thereof BASF SE (DE) 2014-09-02 US disclosed
US-8710093-B2 Synthesis of amines and intermediates for the synthesis thereof BASF SE Ludwigshafen (DE) 2014-04-29 US disclosed
EP-2666772-A1 Synthesis of amines and intermediates for the synthesis thereof BASF SE (DE) 2013-11-27 EP disclosed
US-20120220782-A1 SYNTHESIS OF AMINES AND INTERMEDIATES FOR THE SYNTHESIS THEREOF BERENS ULRICH (DE) 2012-08-30 US disclosed
US-20120220782-A1 SYNTHESIS OF AMINES AND INTERMEDIATES FOR THE SYNTHESIS THEREOF BERENS ULRICH (DE) 2012-08-30 US disclosed
US-20120220782-A1 SYNTHESIS OF AMINES AND INTERMEDIATES FOR THE SYNTHESIS THEREOF BERENS ULRICH (DE) 2012-08-30 US disclosed
US-7968730-B2 Synthesis of amines and intermediates for the synthesis thereof BASF SE (DE) 2011-06-28 US disclosed
US-20100087660-A1 SYNTHESIS OF AMINES AND INTERMEDIATES FOR THE SYNTHESIS THEREOF BASF SE (DE) 2010-04-08 US disclosed
US-20100087660-A1 SYNTHESIS OF AMINES AND INTERMEDIATES FOR THE SYNTHESIS THEREOF BASF SE (DE) 2010-04-08 US disclosed
US-20100087660-A1 SYNTHESIS OF AMINES AND INTERMEDIATES FOR THE SYNTHESIS THEREOF BASF SE (DE) 2010-04-08 US disclosed
US-7645886-B2 Synthesis of amines and intermediates for the synthesis thereof Ciba Specialty Corporation (US) 2010-01-12 US disclosed
US-7645886-B2 Synthesis of amines and intermediates for the synthesis thereof Ciba Specialty Corporation (US) 2010-01-12 US disclosed
US-7645886-B2 Synthesis of amines and intermediates for the synthesis thereof Ciba Specialty Corporation (US) 2010-01-12 US disclosed
US-20060058367-A1 Synthesis of amines and intermediates for the synthesis thereof CIBA CORPORATION 2006-03-16 US disclosed
EP-1572647-A2 SYNTHESIS OF AMINES AND INTERMEDIATES FOR THE SYNTHESIS THEREOF Ciba SC Holding AG (CH) 2005-09-14 EP disclosed
WO-2004056769-A2 SYNTHESIS OF AMINES AND INTERMEDIATES FOR THE SYNTHESIS THEREOF CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2004-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087660-A1 SYNTHESIS OF AMINES AND INTERMEDIATES FOR THE SYNTHESIS THEREOF PNMT, HNMT, SMS CDC25A 1402/4885CACNA1G 3404/4885CACNA1H 3501/4885
US-20060058367-A1 Synthesis of amines and intermediates for the synthesis thereof PNMT, HNMT, MAOA CDC25A 1434/4885CACNA1G 3008/4885CACNA1H 3166/4885
US-20120220782-A1 SYNTHESIS OF AMINES AND INTERMEDIATES FOR THE SYNTHESIS THEREOF PNMT, HNMT, SMS CDC25A 1402/4885CACNA1G 3404/4885CACNA1H 3501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.